Results 51 to 60 of about 3,606 (169)

Topiramate‐induced acute angle closure with suprachoroidal effusion: Insights from a novel ultra‐wide‐field OCT device

Acta Ophthalmologica, Volume 104, Issue 3, Page e356-e359, May 2026.
Michael Hafner, Nicolas Pensel, Nicolas C. D. Scherer, Marc J. Mackert, Siegfried G. Priglinger, Leonie F. Keidel, Maximilian J. Gerhardt   +6 more
wiley   +1 more source

A novel stability indicating RP-HPLC method of related substances for dorzolamide hydrochloride and timolol maleate in glaucoma treatment ophthalmic formulation

Discover Chemistry
A sensitive and simultaneous RP-HPLC strategy has been developed for analysing timolol maleate and dorzolamide hydrochloride along with their related substances.
Harmeet Kaur Kohli, Satish K. Ghumare, Vijay A. Bagul   +2 more
doaj   +1 more source

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2009
Miguel A Teus1, Stefano Miglior2, Guna Laganovska3, Lasma Volksone4, Bozena Romanowska-Dixon5, Roman Gos6, Gábor Holló7, for the C-05-25 Study Group81Hospital Príncipe de Astúrias, Universidad de Alcal& ...
Miguel A Teus, Stefano Miglior, Guna Laganovska, et al   +3 more
doaj  

The Effect of Dorzolamide Ophthalmic Drops in the Treatment of Patients with Central Serous Chorioretinopathy [PDF]

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Background and Objective: Central Serous Chorioretinopathy (CSCR) is a common retinal disorder. The aim of this study was to evaluate the effectiveness of 2% dorzolamide eye drops in accelerating the recovery from acute CSCR.
R Ebrahimi, A Moradi, B Heydari, Gh Yaghoobi, MA Yaghoubi   +4 more
doaj  

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Clinical Ophthalmology, 2012
Graham Anthony Auger, Mathew Raynor, Simon LongstaffOphthalmology Department, Royal Hallamshire Hospital, Sheffield, South Yorkshire, United KingdomBackground: This study aimed to determine the impact of switching patients requiring multiple drug ...
Auger GA, Raynor M, Longstaff S
doaj  

Suspected Dorzolamide–Induced Delayed Hypersensitivity Blepharitis in Dogs

Acta Veterinaria
The aim was to investigate the incidence, clinical presentation, and potential risk factors for suspected dorzolamide-induced blepharitis (DIB), in dogs diagnosed with glaucoma or hereditary glaucoma predisposition.
Grozdanić Sinisa, Luzhetskii Sergei, Lazić Tatjana, Milčić-Matić Natalija   +3 more
doaj   +1 more source

Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study

Journal of Current Ophthalmology, 2019
Purpose: To assess the efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab (IVB) injection on anatomic and functional results in eyes affected with diabetic macular edema (DME).
Ahmad Mirshahi, Ramin Tadayoni, Navid Mohsenzadeh, Talieh Saeidi Rezvani, Mojtaba Abrishami   +4 more
doaj   +1 more source

Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma

Kaohsiung Journal of Medical Sciences, 2016
In our study we aimed to evaluate the short-term effects of dorzolamide/timolol on ocular perfusion pressure and retrobulbar blood flow in patients with pseudoexfoliative glaucoma (PXG).
Mustafa Eliacik, Sevil Karaman Erdur, Inci Baltepe Altıok, Gokhan Gulkilik, Cemile Anil Aslan, Faruk Kaya   +5 more
doaj   +1 more source

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

Clinical Ophthalmology, 2015
Yoshie Shimizu,1 Shunsuke Nakakura,1 Makiko Nishiyama,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, 2Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences ...
Shimizu Y, Nakakura S, Nishiyama M, Tabuchi H, Kiuchi Y   +4 more
doaj  

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit
Daniela Vullo, R. Siva Sai Kumar, Andrea Scozzafava, James G. Ferry, Claudiu T. Supuran   +4 more
doaj   +1 more source